Publications/ Indonesia
 |
| Published by Pacific
Bridge Medical |
July 2005 |
| By Ames Gross and Rachel
Weintraub |
|
The pharmaceutical market in Indonesia
is currently valued at around $350 million. More than
50 percent of the market is comprised of imported products,
with a large portion coming from the U.S., Germany,
Switzerland and Japan. Foreign companies importing
finished products or raw materials into Indonesia are
required to obtain an import license from the Ministry
of Health. The National Agency of Drug and Food Control
(NA-DFC) is responsible for ensuring the safety, quality
and efficacy of pharmaceuticals in Indonesia. The NA-DFC
also handles the drug application review process and
grants drug approvals in the form of a marketing authorization
license. |
|
|
| Published by Pacific
Bridge Medical |
December
1999 |
| By Ames Gross |
|
| Since 1997, Indonesia has battled its worst
economic crisis in decades. Therefore, it is no surprise
that Indonesia’s healthcare industry is facing
significant challenges. This article discusses the medical
device market in Indonesia and its potential for growth.
The medical device registration process is described,
providing details of the two-step process required for
registration. |
|
|
| Published in Clinica,
a publication of PJB Publications, Ltd. |
February 1994 |
| By Ames Gross |
|
| Through an increased prosperity
from export earnings, the Indonesian government has been
able to focus more attention towards enhancing living
standards. Hospitals have access to technologically-advanced
equipment and public health centers are growing at a
rate of about 4% per year. In 1993, Indonesia’s
medical device market was worth approximately $105 million.
This article describes the medical device situation in
Indonesia and the government’s role in medical
device purchasing and registration procedures. |
|
Back to Top
|
Asia
China & Hong Kong
India
Indonesia
Japan
Korea
Malaysia
The Philippines
Singapore
Taiwan
Thailand
Vietnam
|
